BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Oct 27, 2026; 18(10): 121503
Published online Oct 27, 2026. doi: 10.4240/wjgs.121503
Table 4 Multivariate logistic regression analysis of predictive factors for the very high-risk group of gastrointestinal stromal tumor
Variable
β
Standard error
Wald χ2
OR
95%CI for OR
P value
Palpable abdominal mass (yes vs no)0.7010.6051.3432.020.62-6.610.246
Asymptomatic (yes vs no)-0.2850.6210.2110.750.22-2.540.646
Hemoglobin (g/L)-0.0120.0180.4440.990.95-1.030.505
Platelet count (× 109/L)0.0050.0031.8521.011.00-1.010.173
NLR0.2980.1802.7411.350.95-1.920.098
Albumin (g/L)-0.0810.0671.4630.920.81-1.050.226
Tumor location (non-gastric vs gastric)0.5220.5111.0441.690.62-4.590.307
Maximum tumor diameter (cm)0.2650.08010.9841.301.11-1.520.001
NAR (%)0.1160.02916.0241.121.06-1.19< 0.001
Growth pattern (mixed intra- and extraluminal vs no)0.4500.5420.6891.570.54-4.540.407
Irregular morphology (yes vs no)0.6550.5911.2291.930.61-6.130.268
Ill-defined margin (yes vs no)0.6120.5451.2621.840.63-5.360.261
Heterogeneous enhancement (yes vs no)0.8840.7251.4872.420.58-10.050.223
Marked enhancement (yes vs no)0.3310.4810.4741.390.54-3.570.491
Signs of adjacent organ invasion (yes vs no)0.9810.6322.4102.670.77-9.210.121
Constant-9.8562.34517.656--< 0.001


Write to the Help Desk